nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—HTR2A—arteriole—focal segmental glomerulosclerosis	0.0568	0.171	CbGeAlD
Trifluoperazine—S100A4—nephron tubule—focal segmental glomerulosclerosis	0.0306	0.0918	CbGeAlD
Trifluoperazine—S100A4—kidney—focal segmental glomerulosclerosis	0.0269	0.0807	CbGeAlD
Trifluoperazine—S100A4—cortex of kidney—focal segmental glomerulosclerosis	0.0262	0.0786	CbGeAlD
Trifluoperazine—UGT1A4—kidney—focal segmental glomerulosclerosis	0.0236	0.0709	CbGeAlD
Trifluoperazine—CALM2—endothelium—focal segmental glomerulosclerosis	0.0192	0.0577	CbGeAlD
Trifluoperazine—CALM1—endothelium—focal segmental glomerulosclerosis	0.0191	0.0575	CbGeAlD
Trifluoperazine—XDH—kidney—focal segmental glomerulosclerosis	0.0172	0.0517	CbGeAlD
Trifluoperazine—Pigmentation disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0117	0.112	CcSEcCtD
Trifluoperazine—HTR2A—endothelium—focal segmental glomerulosclerosis	0.0117	0.035	CbGeAlD
Trifluoperazine—CALM3—nephron tubule—focal segmental glomerulosclerosis	0.0112	0.0337	CbGeAlD
Trifluoperazine—SIGMAR1—nephron tubule—focal segmental glomerulosclerosis	0.01	0.0301	CbGeAlD
Trifluoperazine—CALM3—cortex of kidney—focal segmental glomerulosclerosis	0.00959	0.0288	CbGeAlD
Trifluoperazine—CALM2—nephron tubule—focal segmental glomerulosclerosis	0.0088	0.0264	CbGeAlD
Trifluoperazine—CALM1—nephron tubule—focal segmental glomerulosclerosis	0.00876	0.0263	CbGeAlD
Trifluoperazine—SIGMAR1—cortex of kidney—focal segmental glomerulosclerosis	0.00857	0.0258	CbGeAlD
Trifluoperazine—Thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00834	0.08	CcSEcCtD
Trifluoperazine—CALM2—kidney—focal segmental glomerulosclerosis	0.00774	0.0232	CbGeAlD
Trifluoperazine—CALM1—kidney—focal segmental glomerulosclerosis	0.0077	0.0231	CbGeAlD
Trifluoperazine—CALM2—cortex of kidney—focal segmental glomerulosclerosis	0.00753	0.0226	CbGeAlD
Trifluoperazine—CALM1—cortex of kidney—focal segmental glomerulosclerosis	0.0075	0.0225	CbGeAlD
Trifluoperazine—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.0494	CcSEcCtD
Trifluoperazine—HTR2A—kidney—focal segmental glomerulosclerosis	0.00469	0.0141	CbGeAlD
Trifluoperazine—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00465	0.0446	CcSEcCtD
Trifluoperazine—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.0427	CcSEcCtD
Trifluoperazine—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00391	0.0375	CcSEcCtD
Trifluoperazine—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.0035	0.0335	CcSEcCtD
Trifluoperazine—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.0035	0.0105	CbGeAlD
Trifluoperazine—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00316	0.0303	CcSEcCtD
Trifluoperazine—ABCB1—kidney—focal segmental glomerulosclerosis	0.00307	0.00923	CbGeAlD
Trifluoperazine—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00302	0.029	CcSEcCtD
Trifluoperazine—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.00299	0.00899	CbGeAlD
Trifluoperazine—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.0281	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00291	0.0279	CcSEcCtD
Trifluoperazine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.024	CcSEcCtD
Trifluoperazine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.0235	CcSEcCtD
Trifluoperazine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00241	0.0231	CcSEcCtD
Trifluoperazine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.0214	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.0212	CcSEcCtD
Trifluoperazine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.0204	CcSEcCtD
Trifluoperazine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.0159	CcSEcCtD
Trifluoperazine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.0158	CcSEcCtD
Trifluoperazine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.0154	CcSEcCtD
Trifluoperazine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0154	CcSEcCtD
Trifluoperazine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0151	CcSEcCtD
Trifluoperazine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.015	CcSEcCtD
Trifluoperazine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.0147	CcSEcCtD
Trifluoperazine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.0143	CcSEcCtD
Trifluoperazine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.0142	CcSEcCtD
Trifluoperazine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.0136	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.0134	CcSEcCtD
Trifluoperazine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.013	CcSEcCtD
Trifluoperazine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.0128	CcSEcCtD
Trifluoperazine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.0121	CcSEcCtD
Trifluoperazine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0119	CcSEcCtD
Trifluoperazine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0119	CcSEcCtD
Trifluoperazine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.0116	CcSEcCtD
Trifluoperazine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.0115	CcSEcCtD
Trifluoperazine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0114	CcSEcCtD
Trifluoperazine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0106	CcSEcCtD
Trifluoperazine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.0106	CcSEcCtD
Trifluoperazine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00986	CcSEcCtD
Trifluoperazine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.0096	CcSEcCtD
Trifluoperazine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000988	0.00946	CcSEcCtD
Trifluoperazine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000923	0.00885	CcSEcCtD
Trifluoperazine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00088	0.00843	CcSEcCtD
Trifluoperazine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000879	0.00843	CcSEcCtD
Trifluoperazine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000874	0.00838	CcSEcCtD
Trifluoperazine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000829	0.00795	CcSEcCtD
Trifluoperazine—Acepromazine—ALB—focal segmental glomerulosclerosis	0.000721	0.193	CrCbGaD
Trifluoperazine—Thioproperazine—ALB—focal segmental glomerulosclerosis	0.000705	0.189	CrCbGaD
Trifluoperazine—Thiothixene—ALB—focal segmental glomerulosclerosis	0.000693	0.186	CrCbGaD
Trifluoperazine—Pipotiazine—ALB—focal segmental glomerulosclerosis	0.000693	0.186	CrCbGaD
Trifluoperazine—Clomipramine—ALB—focal segmental glomerulosclerosis	0.000548	0.147	CrCbGaD
Trifluoperazine—Chlorpromazine—ALB—focal segmental glomerulosclerosis	0.000376	0.101	CrCbGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000194	0.000348	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000194	0.000347	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000194	0.000347	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000194	0.000347	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000191	0.000341	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000191	0.000341	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00019	0.00034	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00019	0.000339	CbGpPWpGaD
Trifluoperazine—CALM3—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000186	0.000333	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000184	0.00033	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000184	0.000329	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000183	0.000327	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000181	0.000325	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000181	0.000324	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000181	0.000323	CbGpPWpGaD
Trifluoperazine—CALM2—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00018	0.000322	CbGpPWpGaD
Trifluoperazine—CALM1—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00018	0.000322	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00018	0.000321	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000178	0.000319	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000178	0.000318	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—ALB—focal segmental glomerulosclerosis	0.000177	0.000317	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—ALB—focal segmental glomerulosclerosis	0.000177	0.000317	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000177	0.000316	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000177	0.000316	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000176	0.000316	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000175	0.000313	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000175	0.000313	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000174	0.000312	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000174	0.000311	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000173	0.00031	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000173	0.000309	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000173	0.000309	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000172	0.000308	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000171	0.000305	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000171	0.000305	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00017	0.000303	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000167	0.0003	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000165	0.000295	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000164	0.000294	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000164	0.000293	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000164	0.000293	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000162	0.000289	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000161	0.000289	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000161	0.000289	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000159	0.000284	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000158	0.000283	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000158	0.000282	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000156	0.000279	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000156	0.000279	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000154	0.000275	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000153	0.000274	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000153	0.000273	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000152	0.000272	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000152	0.000272	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000152	0.000272	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000152	0.000271	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD79A—focal segmental glomerulosclerosis	0.000152	0.000271	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000151	0.000269	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00015	0.000269	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00015	0.000269	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00015	0.000268	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000149	0.000267	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000149	0.000267	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000149	0.000266	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000149	0.000266	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000148	0.000265	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000148	0.000264	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000147	0.000264	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000147	0.000264	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000147	0.000263	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000147	0.000263	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000147	0.000263	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000147	0.000263	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000147	0.000263	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000147	0.000262	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD79A—focal segmental glomerulosclerosis	0.000147	0.000262	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD79A—focal segmental glomerulosclerosis	0.000147	0.000262	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000146	0.000262	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000145	0.00026	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000145	0.000259	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00014	0.00025	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000139	0.000249	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000137	0.000245	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000137	0.000245	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000136	0.000244	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000135	0.000242	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000134	0.00024	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000134	0.00024	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000133	0.000238	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000132	0.000237	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000132	0.000237	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000132	0.000237	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000131	0.000234	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000131	0.000234	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000128	0.000228	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000127	0.000228	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000126	0.000226	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000126	0.000225	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000125	0.000224	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000125	0.000223	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000125	0.000223	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000124	0.000222	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000124	0.000221	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000123	0.000221	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000123	0.00022	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000121	0.000216	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000121	0.000216	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000121	0.000216	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000121	0.000216	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00012	0.000215	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00012	0.000215	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD40LG—focal segmental glomerulosclerosis	0.00012	0.000214	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD40LG—focal segmental glomerulosclerosis	0.00012	0.000214	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000117	0.000209	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000117	0.000209	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000116	0.000208	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000115	0.000205	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000115	0.000205	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000114	0.000203	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000113	0.000202	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000113	0.000202	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000112	0.000201	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000112	0.000201	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—LPL—focal segmental glomerulosclerosis	0.000112	0.0002	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00011	0.000196	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00011	0.000196	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000109	0.000196	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000109	0.000195	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000109	0.000195	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—LPL—focal segmental glomerulosclerosis	0.000108	0.000194	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—LPL—focal segmental glomerulosclerosis	0.000108	0.000194	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000104	0.000186	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000104	0.000185	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000103	0.000184	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000103	0.000183	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000101	0.00018	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000101	0.00018	CbGpPWpGaD
Trifluoperazine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	9.96e-05	0.000178	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.89e-05	0.000177	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.73e-05	0.000174	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.71e-05	0.000174	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.71e-05	0.000174	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—TGFB1—focal segmental glomerulosclerosis	9.6e-05	0.000172	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.6e-05	0.000172	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.56e-05	0.000171	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.53e-05	0.000171	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.53e-05	0.000171	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.45e-05	0.000169	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.44e-05	0.000169	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.42e-05	0.000169	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—LPL—focal segmental glomerulosclerosis	9.38e-05	0.000168	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.35e-05	0.000167	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.3e-05	0.000166	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	9.3e-05	0.000166	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—TGFB1—focal segmental glomerulosclerosis	9.29e-05	0.000166	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—TGFB1—focal segmental glomerulosclerosis	9.29e-05	0.000166	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.27e-05	0.000166	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.25e-05	0.000165	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.22e-05	0.000165	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.22e-05	0.000165	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.09e-05	0.000163	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—LPL—focal segmental glomerulosclerosis	9.07e-05	0.000162	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—LPL—focal segmental glomerulosclerosis	9.07e-05	0.000162	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.95e-05	0.00016	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.93e-05	0.00016	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.78e-05	0.000157	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.76e-05	0.000157	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—NOS2—focal segmental glomerulosclerosis	8.74e-05	0.000156	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.64e-05	0.000155	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.6e-05	0.000154	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—NOS2—focal segmental glomerulosclerosis	8.46e-05	0.000151	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—NOS2—focal segmental glomerulosclerosis	8.46e-05	0.000151	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	8.36e-05	0.00015	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.21e-05	0.000147	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	8.18e-05	0.000146	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.08e-05	0.000145	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.08e-05	0.000145	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.06e-05	0.000144	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—AGT—focal segmental glomerulosclerosis	8.02e-05	0.000143	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.93e-05	0.000142	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.91e-05	0.000142	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.84e-05	0.00014	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.82e-05	0.00014	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.82e-05	0.00014	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AGT—focal segmental glomerulosclerosis	7.76e-05	0.000139	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AGT—focal segmental glomerulosclerosis	7.76e-05	0.000139	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.59e-05	0.000136	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.58e-05	0.000136	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.58e-05	0.000136	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.54e-05	0.000135	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.47e-05	0.000134	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.45e-05	0.000133	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.44e-05	0.000133	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.43e-05	0.000133	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—SERPINE1—focal segmental glomerulosclerosis	7.36e-05	0.000132	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.33e-05	0.000131	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.31e-05	0.000131	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.19e-05	0.000129	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.18e-05	0.000129	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.18e-05	0.000129	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.15e-05	0.000128	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—SERPINE1—focal segmental glomerulosclerosis	7.12e-05	0.000127	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—SERPINE1—focal segmental glomerulosclerosis	7.12e-05	0.000127	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	7.11e-05	0.000127	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.71e-05	0.00012	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.49e-05	0.000116	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.49e-05	0.000116	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.31e-05	0.000113	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.21e-05	0.000111	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.2e-05	0.000111	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.2e-05	0.000111	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—ALB—focal segmental glomerulosclerosis	6.16e-05	0.00011	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.13e-05	0.00011	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.1e-05	0.000109	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.08e-05	0.000109	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	6.08e-05	0.000109	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.99e-05	0.000107	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.99e-05	0.000107	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—ALB—focal segmental glomerulosclerosis	5.95e-05	0.000107	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—ALB—focal segmental glomerulosclerosis	5.95e-05	0.000107	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	5.67e-05	0.000101	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.51e-05	9.85e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.48e-05	9.8e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.16e-05	9.23e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.99e-05	8.92e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.99e-05	8.92e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	4.85e-05	8.68e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.84e-05	8.65e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.76e-05	8.51e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.75e-05	8.49e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.67e-05	8.36e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	4.66e-05	8.35e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.66e-05	8.34e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TGFB1—focal segmental glomerulosclerosis	4.65e-05	8.32e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.54e-05	8.12e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.52e-05	8.08e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TGFB1—focal segmental glomerulosclerosis	4.5e-05	8.05e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TGFB1—focal segmental glomerulosclerosis	4.5e-05	8.05e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.99e-05	7.13e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.95e-05	7.07e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.92e-05	7.02e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.91e-05	7e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.85e-05	6.89e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.84e-05	6.87e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.82e-05	6.84e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.82e-05	6.84e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	3.72e-05	6.66e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.26e-05	5.82e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.15e-05	5.63e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.15e-05	5.63e-05	CbGpPWpGaD
